EDIL3 and breast carcinoma: One study revealed that the levels of sEV-derived endothelial locus-1 (Del-1) were significantly up-regulated in patients with breast cancer relative to healthy people, and could be used as new diagnostic biomarker for patients with breast cancer [108].